Phase III Double-Blind Placebo-Controlled Study of Farnesyl Transferase Inhibitor R115777 in Patients With Refractory Advanced Colorectal Cancer
Journal of Clinical Oncology
Vol 22, No 19 (October 1), 2004: pp. 3950-3957
S. Rao, D. Cunningham, A. de Gramont, W. Scheithauer, M. Smakal, Y. Humblet, G. Kourteva, T. Iveson, T. Andre, J. Dostalova, A. Illes, R. Belly, J.J. Perez-Ruixo, Y.C. Park, P.A. Palmer
DOI: 10.1200/JCO.2004.10.037
Go to journal article.

